Phase 3 trials will begin on a two-dose regimen

Zydus Cadila has been granted permission by India’s drug regulator to conduct a Phase III trial on the two dose regimen of its needle-free Covid-19 vaccine, ZyCoV-D. The Subject Expert Committee (SEC), which advises the drug regulator, granted the company permission to conduct Phase III trials on its vaccine at a meeting last month.

“After careful consideration, the committee recommended that permission be granted to conduct the Phase III clinical trial, subject to the condition that the volume of blood to be withdrawn in the paediatric cohort be in accordance with the National Ethical Guidelines for Biomedical and Health Research Involving Human Participants issued by the ICMR,” according to the meeting minutes.

 

Medically Speaking

Recent Posts

ANTIBIOTIC MISUSE IN INDIA: HOW IT’S MAKING INFECTION TREATMENT MORE CHALLENGING

Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…

6 hours ago

CHILD DIES FROM CHOKING ON CANDY: HOW TO SAFEGUARD AGAINST CHOKING HAZARDS IN YOUNG CHILDREN

Choking is a leading cause of injury and death in young children, particularly those under…

7 hours ago

Video: How Hard Water Leads to Hair Fall and Expert Tips to Combat It

Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…

9 hours ago

“How High Blood Pressure During Pregnancy Is Rising: What Every Expectant Mother Should Know”

Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…

9 hours ago

“Revitalize Your Weight Loss Journey: 6 Powerful Homemade Drinks to Naturally Melt Away Fat!”

"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…

9 hours ago

“Revitalize Your Weight Loss Journey: 8 Powerful Fat-Flushing Drinks to Boost Your Results!”

"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…

9 hours ago